BLIS Technologies Ltd
NZX:BLT

Watchlist Manager
BLIS Technologies Ltd Logo
BLIS Technologies Ltd
NZX:BLT
Watchlist
Price: 0.015 NZD -6.25% Market Closed
Market Cap: 19.2m NZD
Have any thoughts about
BLIS Technologies Ltd?
Write Note

BLIS Technologies Ltd
Total Liabilities & Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

BLIS Technologies Ltd
Total Liabilities & Equity Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities & Equity CAGR 3Y CAGR 5Y CAGR 10Y
BLIS Technologies Ltd
NZX:BLT
Total Liabilities & Equity
NZ$12.9m
CAGR 3-Years
18%
CAGR 5-Years
20%
CAGR 10-Years
N/A
A
AFT Pharmaceuticals Ltd
NZX:AFT
Total Liabilities & Equity
NZ$147.9m
CAGR 3-Years
12%
CAGR 5-Years
12%
CAGR 10-Years
N/A
Cannasouth Ltd
NZX:CBD
Total Liabilities & Equity
NZ$55.5m
CAGR 3-Years
56%
CAGR 5-Years
75%
CAGR 10-Years
N/A
Rua Bioscience Ltd
NZX:RUA
Total Liabilities & Equity
NZ$7.7m
CAGR 3-Years
-37%
CAGR 5-Years
-7%
CAGR 10-Years
N/A
G
Greenfern Industries Ltd
NZX:GFI
Total Liabilities & Equity
NZ$3.9m
CAGR 3-Years
5%
CAGR 5-Years
21%
CAGR 10-Years
N/A
No Stocks Found

BLIS Technologies Ltd
Glance View

Market Cap
19.2m NZD
Industry
Pharmaceuticals

BLIS Technologies Ltd. engages in the development of healthcare products based on strains of bacteria that produce Bacteriocin activity. The company is headquartered in Dunedin, Otago. The company went IPO on 2001-07-30. The firm is also engaged in supply of healthcare ingredients and the manufacture of part and finished goods and food products for sale in domestic and international markets. The firm supplies BLIS-branded finished goods. The firm's products include BLIS K12 and BLIS M18, which are oral probiotics providing protection for ear, nose and throat health, halitosis (bad breath), gums and teeth health and immune support. The firm distributes its products through Stratum Nutrition in North America, NZPR Group in China, and Bluestone Pharma in Europe and Middle East. Its other BLIS branded products include Throat Guard EVERYDAY BLIS K12, Travel Guard BLIS K12, Fresh Breath Kit K12 and Toddler Protect BLIS K12 Powder for Toddlers.

BLT Intrinsic Value
0.01 NZD
Overvaluation 34%
Intrinsic Value
Price

See Also

What is BLIS Technologies Ltd's Total Liabilities & Equity?
Total Liabilities & Equity
12.9m NZD

Based on the financial report for Mar 31, 2024, BLIS Technologies Ltd's Total Liabilities & Equity amounts to 12.9m NZD.

What is BLIS Technologies Ltd's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 5Y
20%

Over the last year, the Total Liabilities & Equity growth was 1%. The average annual Total Liabilities & Equity growth rates for BLIS Technologies Ltd have been 18% over the past three years , 20% over the past five years .

Back to Top